{
  "ticker": "LLY",
  "target_date": "2024-12-25",
  "actual_date": "2024-12-24",
  "collected_at": "2025-12-08T11:11:38.124122",
  "price": {
    "open": 785.51,
    "high": 791.84,
    "low": 781.27,
    "close": 789.7791748046875,
    "volume": 1165400,
    "change_1d_pct": -0.08,
    "change_7d_pct": 0.83,
    "change_30d_pct": -4.26
  },
  "technicals": {
    "rsi_14": 36.59,
    "sma_20": 788.04,
    "sma_50": 809.65,
    "macd": -7.742,
    "macd_signal": -9.298,
    "macd_histogram": 1.556,
    "bb_upper": 827.35,
    "bb_lower": 748.73,
    "price_vs_sma20_pct": 0.22,
    "price_vs_sma50_pct": -2.45,
    "volume_ratio": 0.33
  },
  "fundamentals": {
    "market_cap": 891158724608,
    "pe_ratio": 48.706028,
    "forward_pe": 43.869816,
    "price_to_book": 37.42809,
    "price_to_sales": 14.997673,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.6,
    "pct_from_52w_low": 59.37
  },
  "macro": {
    "spy": {
      "price": 596.08,
      "change_1d_pct": 1.11,
      "change_7d_pct": -0.57
    },
    "vix": {
      "level": 14.27,
      "signal": "LOW_FEAR"
    },
    "treasury_10y": {
      "yield_pct": 4.59
    },
    "dollar_index": {
      "level": 108.26
    },
    "gold": {
      "price": 2620.0
    },
    "regime": "BEAR_NORMAL"
  },
  "news": [
    {
      "headline": "Jim Cramer Says Novo Nordisk A/S (NVO) Can\u2019t Exceed Eli Lilly",
      "source": "Yahoo",
      "datetime": 1735128732,
      "summary": "We recently compiled a list of the Jim Cramer Discusses 17 Stocks And Blasts Zero Day Options. In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against the other stocks. In his second appearance on Squawk on the Street after the Fed\u2019s interest rate cut, Jim Cr",
      "url": "https://finnhub.io/api/news?id=d4ef83561a3d93b634f97e1dba7e549385b8dc422631aaa982b4c3a6de606e6d"
    },
    {
      "headline": "Eli Lilly and Co (LLY) Is Among Billionaire Coleman\u2019s Top Picks",
      "source": "Yahoo",
      "datetime": 1735127590,
      "summary": "We recently compiled a list of the Tech Billionaire Chase Coleman\u2019s Top 10 Stock Picks. In this article, we are going to take a look at where Eli Lilly and Co (NYSE:LLY) stands against the other top stock picks of Tech Billionaire Chase Coleman. \u201cTiger cub\u201d Chase Coleman continues to shape the inves",
      "url": "https://finnhub.io/api/news?id=263724c2fcf91be94375f3245aca3d38b2bb391a5984eab65cde89aec8b9a17c"
    },
    {
      "headline": "Novo Nordisk is 'losing its pep' in GLP-1 race: BMO analyst",
      "source": "Yahoo",
      "datetime": 1735126214,
      "summary": "Coming off of Novo Nordisk's (NVO) sharp stock decline after its experimental weight-loss shot CagriSema was found to help recipients lose less weight than previously forecasted, BMO Capital Markets cut its price target on the pharmaceutical company from $156 to $105 per share. \"This was supposed to",
      "url": "https://finnhub.io/api/news?id=dc451877af6528648c9f98a400db1211a380257b2ab5b236d5154b20ce503913"
    },
    {
      "headline": "The Big Companies Funding Trump\u2019s Inauguration Despite Denouncing Jan. 6",
      "source": "Yahoo",
      "datetime": 1735092000,
      "summary": "Now, many of those companies are lining up to fund  Donald Trump\u2019s  inauguration.  The Wall Street Journal has identified at least 11 companies and trade associations that are backing the inauguration, which is on track to be the most lucrative ever, after earlier pledging to suspend or reconsider p",
      "url": "https://finnhub.io/api/news?id=2700ac93f946aa376f045caca3020d42bef82c43aabb16b9dad24436bd8c7ef5"
    },
    {
      "headline": "Eli Lilly (LLY) Stock Sinks As Market Gains: What You Should Know",
      "source": "Yahoo",
      "datetime": 1735080320,
      "summary": "In the most recent trading session, Eli Lilly (LLY) closed at $795.67, indicating a -0.08% shift from the previous trading day.",
      "url": "https://finnhub.io/api/news?id=c4bd767bd7c7dec61d4fbe5f1e5fe2af6ec255e1ffd8957c6b19f171d8d1deff"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2024-12-17",
      "description": "xslF345X05/wk-form4_1734470584.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000291/xslF345X05/wk-form4_1734470584.xml"
    },
    {
      "form": "4",
      "date": "2024-12-17",
      "description": "xslF345X05/wk-form4_1734470498.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000289/xslF345X05/wk-form4_1734470498.xml"
    },
    {
      "form": "4",
      "date": "2024-12-17",
      "description": "xslF345X05/wk-form4_1734470366.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000287/xslF345X05/wk-form4_1734470366.xml"
    },
    {
      "form": "4",
      "date": "2024-12-17",
      "description": "xslF345X05/wk-form4_1734470270.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000285/xslF345X05/wk-form4_1734470270.xml"
    },
    {
      "form": "4",
      "date": "2024-12-17",
      "description": "xslF345X05/wk-form4_1734470180.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000283/xslF345X05/wk-form4_1734470180.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}